LightScience aims to spark a revolution in remote blood testing and digital health. Its patented technology is able to fully digitalize the analytic pipeline, providing patients, doctors, and healthcare stakeholders with fast, reliable, and human-validated data that can be gathered from anywhere there is an Internet connection. LightScience is currently developing two distinct product lines: MASSScan, a versatile scanner designed for mass screening, that can be integrated with multiple devices in order to detect infectious diseases (e.g. Covid-19) and give results in less than a minute; and myLab, a portable device specifically designed to bring the laboratory to the patient, avoiding costly and time-consuming trips to the lab and allowing patients and physicians alike to optimize their therapy with real-time data.